Systemic listeriosis following vaccination with the attenuated Listeria monocytogenes therapeutic vaccine, ADXS11-001
about
hrHPV E5 oncoprotein: immune evasion and related immunotherapies.Human papillomavirus-driven immune deviation: challenge and novel opportunity for immunotherapy.Listeria monocytogenes mutants defective in gallbladder replication represent safety-enhanced vaccine delivery platforms.Synthetic vaccine particles for durable cytolytic T lymphocyte responses and anti-tumor immunotherapy.as a Vector for Cancer Immunotherapy: Current Understanding and Progress
P2860
Systemic listeriosis following vaccination with the attenuated Listeria monocytogenes therapeutic vaccine, ADXS11-001
description
wetenschappelijk artikel (gepubliceerd op 2016/04/02)
@nl
наукова стаття, опублікована у квітні 2016
@uk
name
Systemic listeriosis following ...... herapeutic vaccine, ADXS11-001
@en
type
label
Systemic listeriosis following ...... herapeutic vaccine, ADXS11-001
@en
prefLabel
Systemic listeriosis following ...... herapeutic vaccine, ADXS11-001
@en
P2093
P2860
P921
P1476
Systemic listeriosis following ...... herapeutic vaccine, ADXS11-001
@en
P2093
Joseph J Sacco
Kevin J Harrington
Mererid Evans
Ned Powell
Richard J Shaw
Terry M Jones
P2860
P304
P356
10.1080/21645515.2015.1121338
P407
P50
P577
2016-04-02T00:00:00Z